DalsnaFinance › IPOs › Odyssey Therapeutics › IPO
Odyssey Therapeutics, Inc. completed its initial public offering on NASDAQ on May 8, 2026, pricing at $18.00 a share.
| Ticker | ODTX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | May 8, 2026 |
| Offering price | $18.00 |
| Shares offered | 15,500,000 |
| Total raised | $279M |
Odyssey Therapeutics, Inc. sold 15,500,000 shares at $18.00 each on NASDAQ. Multiplied out, that is $279 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $279 million total recorded for the deal.
Measured by money raised, Odyssey Therapeutics, Inc. was the 104th largest of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 342 listings on NASDAQ alone, it is the 60th largest.
May 2026 saw 28 completed IPOs in the site's data; by amount raised, Odyssey Therapeutics, Inc. was the 8th largest of the 21 deals with a recorded size.
Its $18.00 offer price was tied for the 82nd highest (level with 12 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Odyssey Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Odyssey Therapeutics, Inc.. This page is general information, not investment advice.